|
1
|
Jarrett JT and Lansbury PT Jr: Seeding
‘one-dimensional crystallization’ of amyloid: A pathogenic
mechanism in Alzheimer’s disease and scrapie? Cell. 73:1055–1058.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Winblad B, Palmer K, Kivipelto M, Jelic V,
Fratiglioni L, Wahlund LO, Nordberg A, Bäckman L, Albert M,
Almkvist O, et al: Mild cognitive impairment-beyond controversies,
towards a consensus: Report of the international working group on
mild cognitive impairment. J Intern Med. 256:240–246. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Coyle JT, Price DL and DeLong MR:
Alzheimer’s disease: A disorder of cortical cholinergic
innervation. Science. 219:1184–1190. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Alzheimer’s A: 2011 Alzheimer’s disease
facts and figures. W V Med J. 107:82–83. 2011.
|
|
5
|
Colucci L, Bosco M, Fasanaro AM, Gaeta GL,
Ricci G and Amenta F: Alzheimer’s disease costs: What we know and
what we should take into account. J Alzheimers Dis. 42:1311–1324.
2014. View Article : Google Scholar
|
|
6
|
Ittner LM and Gotz J: Amyloid-β and tau -
a toxic pas de deux in Alzheimer’s disease. Nat Rev Neurosci.
12:65–72. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Harold D, Abraham R, Hollingworth P, Sims
R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K,
Williams A, et al: Genome-wide association study identifies
variants at CLU and PICALM associated with Alzheimer’s disease. Nat
Genet. 41:1088–1093. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bertram L and Tanzi RE: Alzheimer disease:
New light on an old CLU. Nat Rev Neurol. 6:11–13. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Selkoe DJ: The cell biology of
beta-amyloid precursor protein and presenilin in Alzheimer’s
disease. Trends Cell Biol. 8:447–453. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Love S and Kehoe PG: Clearance of Abeta
from the brain in Alzheimer’s disease. Foreword. Brain Pathol.
18:2392008. View Article : Google Scholar
|
|
11
|
Akwa Y, Allain H, Bentue-Ferrer D, Berr C,
Bordet R, Geerts H, Nieoullon A, Onteniente B and Vercelletto M:
Neuroprotection and neurodegenerative diseases: From biology to
clinical practice. Alzheimer Dis Assoc Disord. 19:226–239. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yao J, Irwin RW, Zhao L, Nilsen J,
Hamilton RT and Brinton RD: Mitochondrial bioenergetic deficit
precedes Alzheimer’s pathology in female mouse model of Alzheimer’s
disease. Proc Natl Acad Sci USA. 106:14670–14675. 2009. View Article : Google Scholar
|
|
13
|
Zeng Z, Xu J and Zheng W: Artemisinin
protects PC12 cells against β-amyloid-induced apoptosis through
activation of the ERK1/2 signaling pathway. Redox Biol. 12:625–633.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Godyn J, Jonczyk J, Panek D and Malawska
B: Therapeutic strategies for Alzheimer’s disease in clinical
trials. Pharmacol Rep. 68:127–138. 2016. View Article : Google Scholar
|
|
15
|
Cummings JL, Morstorf T and Zhong K:
Alzheimer’s disease drug-development pipeline: Few candidates,
frequent failures. Alzheimers Res Ther. 6:372014. View Article : Google Scholar
|
|
16
|
Selkoe DJ and Hardy J: The amyloid
hypothesis of Alzheimer’s disease at 25 years. EMBO Mol Med.
8:595–608. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Abidov M, Crendal F, Grachev S, Seifulla R
and Ziegenfuss T: Effect of extracts from Rhodiola rosea and
Rhodiola crenulata (Crassulaceae) roots on ATP content in
mitochondria of skeletal muscles. Bull Exp Biol Med. 136:585–587.
2003. View Article : Google Scholar
|
|
18
|
Zhang J, Zhen YF, Pu-Bu-Ci-Ren, Song LG,
Kong WN, Shao TM, Li X and Chai XQ: Salidroside attenuates beta
amyloid-induced cognitive deficits via modulating oxidative stress
and inflammatory mediators in rat hippocampus. Behav Brain Res.
244:70–81. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu Z, Li X, Simoneau AR, Jafari M and Zi
X: Rhodiola rosea extracts and salidroside decrease the growth of
bladder cancer cell lines via inhibition of the mTOR pathway and
induction of autophagy. Mol Carcinog. 51:257–267. 2012. View Article : Google Scholar
|
|
20
|
Zhang L, Yu H, Zhao X, Lin X, Tan C, Cao G
and Wang Z: Neuroprotective effects of salidroside against
beta-amyloid-induced oxidative stress in SH-SY5Y human
neuroblastoma cells. Neurochem Int. 57:547–555. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu M, Waring JF, Gopalakrishnan M and Li
J: Role of GSK-3beta activation and alpha7 nAChRs in
Abeta(1–42)-induced tau phosphorylation in PC12 cells. J Neurochem.
106:1371–1377. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mahbub AA, Le Maitre CL, Haywood-Small SL,
McDougall GJ, Cross NA and Jordan-Mahy N: Differential effects of
poly-phenols on proliferation and apoptosis in human myeloid and
lymphoid leukemia cell lines. Anticancer Agents Med Chem.
13:1601–1613. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Simon HU, Haj-Yehia A and Levi-Schaffer F:
Role of reactive oxygen species (ROS) in apoptosis induction.
Apoptosis. 5:415–418. 2000. View Article : Google Scholar
|
|
24
|
Ly JD, Grubb DR and Lawen A: The
mitochondrial membrane potential (deltapsi(m)) in apoptosis. An
update Apoptosis. 8:115–128. 2003. View Article : Google Scholar
|
|
25
|
Green DR and Reed JC: Mitochondria and
apoptosis. Science. 281:1309–1312. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bufill E, Bartes A, Moral A, Casadevall T,
Codinachs M, Zapater E, Carles Rovira J, Roura P, Oliva R and Blesa
R: Genetic and environmental factors that may influence in the
senile form of Alzheimer’s disease: Nested case control studies.
Neurologia. 24:108–112. 2009.In Spanish. PubMed/NCBI
|
|
27
|
Di Paolo G and Kim TW: Linking lipids to
Alzheimer’s disease: Cholesterol and beyond. Nat Rev Neurosci.
12:284–296. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Butterfield DA and Boyd-Kimball D:
Oxidative stress, amyloid-β peptide, and altered key molecular
pathways in the pathogenesis and progression of Alzheimer’s
disease. J Alzheimers Dis. 62:1345–1367. 2018. View Article : Google Scholar :
|
|
29
|
Knezevic D and Mizrahi R: Molecular
imaging of neuroinflammation in Alzheimer’s disease and mild
cognitive impairment. Prog Neuropsychopharmacol Biol Psychiatry.
80:123–131. 2018. View Article : Google Scholar
|
|
30
|
Ma YG, Wang JW, Zhang YB, Wang BF, Dai ZJ,
Xie MJ and Kang HF: Salidroside improved cerebrovascular
vasodilation in streptozotocin-induced diabetic rats through
restoring the function of BKCa channel in smooth muscle cells. Cell
Tissue Res. 370:365–377. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu X, Bai Y, Liang L, Feng J and Deng F:
Salidroside improves pulmonary fibrosis by down-regulation of
cathepsin B and NF-κBp65 in rats. Zhong Nan Da Xue Xue Bao Yi Xue
Ban. 42:128–133. 2017.In Chinese. PubMed/NCBI
|
|
32
|
Richter L, Munter LM, Ness J, Hildebrand
PW, Dasari M, Unterreitmeier S, Bulic B, Beyermann M, Gust R, Reif
B, et al: Amyloid beta 42 peptide (Abeta42)-lowering compounds
directly bind to Aβ and interfere with amyloid precursor protein
(APP) transmembrane dimerization. Proc Natl Acad Sci USA.
107:14597–14602. 2010. View Article : Google Scholar
|
|
33
|
Postu PA, Noumedem JAK, Cioanca O,
Hancianu M, Mihasan M, Ciorpac M, Gorgan DL, Petre BA and Hritcu L:
Lactuca capensis reverses memory deficits in Aβ1–42-induced an
animal model of Alzheimer’s disease. J Cell Mol Med. 22:111–122.
2018. View Article : Google Scholar
|
|
34
|
Lu Z and Xu S: ERK1/2 MAP kinases in cell
survival and apoptosis. IUBMB Life. 58:621–631. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Franke TF, Hornik CP, Segev L, Shostak GA
and Sugimoto C: PI3K/Akt and apoptosis: Size matters. Oncogene.
22:8983–8998. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Imai Y, Yamagishi H, Ono Y and Ueda Y:
Versatile inhibitory effects of the flavonoid-derived PI3K/Akt
inhibitor, LY294002, on ATP-binding cassette transporters that
characterize stem cells. Clin Transl Med. 1:242012. View Article : Google Scholar
|
|
37
|
Zhu C, Qi X, Chen Y, Sun B, Dai Y and Gu
Y: PI3K/Akt and MAPK/ERK1/2 signaling pathways are involved in
IGF-1-induced VEGF-C upregulation in breast cancer. J Cancer Res
Clin Oncol. 137:1587–1594. 2011. View Article : Google Scholar : PubMed/NCBI
|
